It is a pharma private limited company based in Indore, Madhya Pradesh, India, established in 2014.
2014 | Indore, Madhya Pradesh, India | ActiveRaounak Drugs Private Limited, a active private limited company, was established on 31 March 2014 in Indore, Madhya Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33111MP2014PTC032643. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.30 Cr and a paid-up capital of ₹1.30 Cr.
It upholds a compliant status. Its leadership includes Aniruddha Deharia (Director), Tulasiram Dehariya (Director), Sanjeev Tiwari (Whole-Time Director). Past directors included Gunasheela Gangadhar Uppin, Gangadhar Chandrashekar Uppin, Sanjeev Tiwari. It holds ₹5.32 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Office No. 102, 01St Floor, Harshdeep Avenue 157, Chikitsak Nagar, Satya Sai, Indore, Madhya Pradesh, 452010.
U33111MP2014PTC032643
032643
31 March 2014
₹1.30 Cr
₹1.30 Cr
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Raounak Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aniruddha Deharia | Director | 21 Mar 2022 | Current |
| Tulasiram Dehariya | Director | 21 Mar 2022 | Current |
| Sanjeev Tiwari | Whole-Time Director | 31 Mar 2014 | Current |
| Alok Lashkari | Additional Director | 03 Dec 2019 | Current |
| Rajesh Kumar Sharma | Managing Director | 09 Jan 2016 | Current |
| Shraddha Tiwari | Director | 23 May 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 May 2015 | Past |
| Pramod Abcsdd | Director | 23 May 2015 | Past |
| Pramod Abcsdd | Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Raounak Drugs Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 0.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2019, Raounak Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹53,177,019.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jan 2025 | Others | ₹5.18 M | Open |
| 29 Oct 2021 | Others | ₹8.00 M | Open |
| 21 Aug 2017 | Others | ₹4.00 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Raounak Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Raounak Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raounak Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others amounted to Rs. 0.52 Cr with Charge ID 101083883 was registered on 17 Jan 2025. was recorded as a recent event.
The activity Aniruddha Deharia was appointed as a Director was appointed as a Director on 21 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
The activity Tulasiram Dehariya was appointed as a Director was appointed as a Director on 21 Mar 2022 & has been associated with this company since 3 years 9 months . was completed.
A charge with Others amounted to Rs. 0.80 Cr with Charge ID 100521153 was registered on 29 Oct 2021. was recorded as a recent event.
The activity Alok Lashkari was appointed as a Additional Director was appointed as a Additional Director on 03 Dec 2019 & has been associated with this company since 6 years 19 days . was completed.
Progress on Raounak Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was documented.
The CIN of Raounak Drugs Private Limited is U33111MP2014PTC032643.
Raounak Drugs Private Limited is headquartered at Office No. 102, 01St Floor, Harshdeep Avenue 157, Chikitsak Nagar, Satya Sai, Indore, Madhya Pradesh, 452010.
Raounak Drugs Private Limited was incorporated on 31 March 2014.
The current directors of Raounak Drugs Private Limited are
The primary industry of Raounak Drugs Private Limited is Pharma.
Raounak Drugs Private Limited is unlisted.
The authorized capital of Raounak Drugs Private Limited is ₹1.30 Cr, and the paid-up capital is ₹1.30 Cr.
The compliance status of Raounak Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX